Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
32 participants
INTERVENTIONAL
2025-03-15
2025-09-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Does twice-daily consumption of 20 grams of Agoge Hemp Protein Powder for 30 days result in detectable levels of THC-COOH, the primary metabolite of THC, in urine samples? Is the supplement well tolerated, and does it affect common clinical safety markers (e.g., liver and kidney function, inflammatory markers)?
This is a single-arm study with no comparison group. All participants will:
* Consume 20 grams of the hemp protein supplement twice daily for 30 days
* Provide blood and urine samples at baseline and Day 30
* Complete weekly surveys assessing adherence, tolerability, and adverse events
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Benefits of Hemp Protein Supplementation During Resistance Training
NCT02529917
A FINEH Protein Trial - Part 1
NCT02366598
The Impact of Plant-based Blends on Skeletal Muscle Protein Synthesis Rates in Older Adults
NCT05917223
Clinical Trial of Protein and Blood Pressure
NCT00107744
The Effect of Ingesting a Novel Algae Protein Source on Rested and Exercised Muscle Protein Synthesis Rates in Older Adults.
NCT06852547
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hemp Protein
Healthy adults consuming 20 grams of Hemp Protein Powder twice a day for 30 days
Hemp protein powder
Agoge Universal Hemp Protein Powder - A certified cannabinoid-free hemp protein powder.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hemp protein powder
Agoge Universal Hemp Protein Powder - A certified cannabinoid-free hemp protein powder.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able and willing to provide informed consent.
* In good general health as determined by medical history and screening.
* No cannabis or hemp product use within the past 90 days and willingness to avoid consuming other hemp-based or cannabinoid-containing products during the study period.
* Willing to take 20 grams of hemp protein powder, twice a day, for 30 days, complete two blood draws, provide two urine samples, and fill out weekly surveys.
Exclusion Criteria
* Regular use of any medications that could interfere with THC metabolism.
* History of substance abuse or dependence within the past year.
* Individuals who are pregnant, lactating, or planning a pregnancy within the next 30 days.
* Known allergy or hypersensitivity to cannabis, hemp, or any component of the study product.
* Participants with chronic liver, kidney, or severe cardiovascular disease.
* Participants with dietary restrictions that may prevent them from consuming the study product.
* Current or recent participation in another research study within 14 days of screening.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National University of Natural Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Brice Thompson
Clinical Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Helfgott Research Institute
Portland, Oregon, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
NUNM Research - Agoge Study Description
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BT10124
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.